Stigmatizing attitudes among nurses toward patients with substance use disorders (SUDs) and Opioid Use Disorder (OUD) represent a significant and pervasive
Background: Melanoma outcomes have improved in recent years as a result of modern systemic therapies. A major molecular feature of melanoma is abnormal telomerase activation; this is most often caused by telomerase reverse transcriptase (TERT) promoter mutations, which occur in 50–82% of cases and are the most common noncoding alteration in this cancer. Telomerase maintains telomere length, allowing melanoma cells to avoid senescence and continue dividing. However, how telomerase activity influences melanoma cell doubling time remains unclear, and the pathways linking TERT expression to faster cell-cycle progression require further study. Although telomerase inhibitors show promise in preclinical models, their clinical use is limited by delayed cytotoxicity and resistance. Materials and Methods: A scoping review was conducted using Scopus, ScienceDirect, MEDLINE/PubMed, and CINAHL (Cumulative Index to Nursing and Allied Health Literature). Keywords included “telomerase,” “melanoma,” “cancer,” “cell proliferation,” and “doubling time,” using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: Telomerase-related biomarkers were found to correlate with disease stage and survival. Suggested therapeutic strategies include enzyme inhibitors, cytotoxic nucleotide incorporation, telomere destabilization, and immunotherapies such as peptide or dendritic cell vaccines, etc. Conclusions: Understanding both telomere-dependent and -independent TERT functions is essential for developing effective biomarkers and therapies that overcome resistance and slow melanoma progression.
Pediatric cholesteatoma is an aggressive but uncommon middle ear condition characterized by keratinizing squamous epithelium that can progressively erode adjacent structures. It is associated with faster bone destruction and higher recurrence rates in children than adults, and its symptoms often resemble chronic otitis media, which may delay diagnosis and treatment. A 4‐year‐old boy presented with persistent foul‐smelling otorrhea from the left ear and conductive hearing loss. Otoscopic examination revealed a retracted tympanic membrane with a whitish epitympanic mass. High‐resolution CT demonstrated soft‐tissue density in the middle ear with scutum erosion. The patient underwent canal wall‐up mastoidectomy with tympanoplasty, and intraoperative findings confirmed cholesteatoma with partial ossicular erosion. This case reflects the insidious clinical presentation of cholesteatoma and emphasizes that chronic otorrhea and unilateral hearing loss may indicate destructive middle ear disease rather than benign infection. Imaging plays a critical role in diagnosis and surgical planning, particularly in detecting bony erosion and disease extent. Maintaining a high index of suspicion for cholesteatoma in children with persistent discharge or unexplained conductive hearing loss is essential. Early diagnosis and timely surgical intervention are crucial to prevent irreversible complications and reduce recurrence risk.